lipoxin A4
Selected indexed studies
- Lipoxin A4 (LXA4) as a Potential Drug for Diabetic Retinopathy. (Medicina (Kaunas), 2025) [PMID:40005295]
- Lipoxin A4: a novel anti-inflammatory molecule? (Thorax, 1995) [PMID:7701445]
- Sirtuin6 and Lipoxin A4 levels are decreased in severe periodontitis. (Clin Oral Investig, 2023) [PMID:37851128]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Lipoxin A4 (LXA4) as a Potential Drug for Diabetic Retinopathy. (2025) pubmed
- Lipoxin A4: a novel anti-inflammatory molecule? (1995) pubmed
- Sirtuin6 and Lipoxin A4 levels are decreased in severe periodontitis. (2023) pubmed
- [Lipoxin A4]. (2015) pubmed
- Lipoxin A4 regulates M1/M2 macrophage polarization via FPR2-IRF pathway. (2022) pubmed
- Lipoxin A4 attenuated dexamethasone-induced muscle atrophy via activation of PGC-1α/Nrf2/TFAM pathway. (2023) pubmed
- Lipoxin A4 Regulates M2 Macrophage-Derived Exosomal miR-25-5p to Protect Cell Pyroptosis in Bronchopulmonary Dysplasia. (2025) pubmed
- Lipoxin A4 attenuates the lung ischaemia reperfusion injury in rats after lung transplantation. (2021) pubmed
- Lipoxin A4 alleviates sepsis-induced acute liver injury by inhibiting inflammatory response and iron overload via JAK2/STAT3 signaling. (2025) pubmed
- Changes of Lipoxin A4 and the Anti-inflammatory Role During Parturition. (2022) pubmed